3I79

Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1)


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.04 Å
  • R-Value Free: 0.258 
  • R-Value Work: 0.213 

wwPDB Validation 3D Report Full Report


This is version 1.3 of the entry. See complete history

Literature

Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors.

Ojo, K.K.Larson, E.T.Keyloun, K.R.Castaneda, L.J.Derocher, A.E.Inampudi, K.K.Kim, J.E.Arakaki, T.L.Murphy, R.C.Zhang, L.Napuli, A.J.Maly, D.J.Verlinde, C.L.Buckner, F.S.Parsons, M.Hol, W.G.Merritt, E.A.Van Voorhis, W.C.

(2010) Nat.Struct.Mol.Biol. 17: 602-607

  • DOI: 10.1038/nsmb.1818
  • Primary Citation of Related Structures:  
  • Also Cited By: 4WG5, 4WG4, 4WG3, 4TZR, 4ONA, 4MXA, 4MX9, 4M97, 4M84, 4JBV, 3V5T, 3V5P, 3V51, 3UQG, 3UQF, 3UPZ, 3UPX, 3T3V, 3T3U, 3SXF, 3NCG, 3N51, 3MWU

  • PubMed Abstract: 
  • New drugs are needed to treat toxoplasmosis. Toxoplasma gondii calcium-dependent protein kinases (TgCDPKs) are attractive targets because they are absent in mammals. We show that TgCDPK1 is inhibited by low nanomolar levels of bumped kinase inhibitor ...

    New drugs are needed to treat toxoplasmosis. Toxoplasma gondii calcium-dependent protein kinases (TgCDPKs) are attractive targets because they are absent in mammals. We show that TgCDPK1 is inhibited by low nanomolar levels of bumped kinase inhibitors (BKIs), compounds inactive against mammalian kinases. Cocrystal structures of TgCDPK1 with BKIs confirm that the structural basis for selectivity is due to the unique glycine gatekeeper residue in the ATP-binding site. We show that BKIs interfere with an early step in T. gondii infection of human cells in culture. Furthermore, we show that TgCDPK1 is the in vivo target of BKIs because T. gondii expressing a glycine to methionine gatekeeper mutant enzyme show significantly decreased sensitivity to BKIs. Thus, design of selective TgCDPK1 inhibitors with low host toxicity may be achievable.


    Related Citations: 
    • Discovery of Potent and Selective Inhibitors of Calcium-Dependent Protein Kinase 1 (CDPK1) from C. parvum and T. gondii.
      Murphy, R.C.,Ojo, K.K.,Larson, E.T.,Castellanos-Gonzalez, A.,Perera, B.G.,Keyloun, K.R.,Kim, J.E.,Bhandari, J.G.,Muller, N.R.,Verlinde, C.L.,White, A.C.,Merritt, E.A.,Van Voorhis, W.C.,Maly, D.J.
      (2010) ACS Med Chem Lett 1: 331


    Organizational Affiliation

    Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Calmodulin-domain protein kinase 1
A
484Toxoplasma gondiiMutation(s): 0 
Gene Names: CDPK1
Find proteins for Q9BJF5 (Toxoplasma gondii)
Go to UniProtKB:  Q9BJF5
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
EDO
Query on EDO

Download SDF File 
Download CCD File 
A
1,2-ETHANEDIOL
ETHYLENE GLYCOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.04 Å
  • R-Value Free: 0.258 
  • R-Value Work: 0.213 
  • Space Group: P 1 21 1
Unit Cell:
Length (Å)Angle (°)
a = 48.144α = 90.00
b = 71.861β = 102.98
c = 67.265γ = 90.00
Software Package:
Software NamePurpose
RESOLVEphasing
HKL-2000data scaling
SCALEPACKdata scaling
REFMACrefinement
Blu-Icedata collection
SOLVEphasing
DENZOdata reduction
HKL-2000data reduction
PDB_EXTRACTdata extraction

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2009-08-11
    Type: Initial release
  • Version 1.1: 2011-07-13
    Type: Advisory, Version format compliance
  • Version 1.2: 2014-11-12
    Type: Database references
  • Version 1.3: 2017-11-01
    Type: Refinement description